PROGRESSIVE CORP/OH/

PGR

CIK 0000080661 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$22.75B
↑+12.2% +$2.47Bvs FY2024 (Q4)
Operating Income
$8.56B
↑+18.6% +$1.34Bvs FY2024 (Q4)
Net Income
$2.95B
↑+25.3% +$595Mvs FY2024 (Q4)
Gross Profit
$8.64B
↑+18.5% +$1.35Bvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
30/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    81D/E 0.37 (under 0.5 = conservative)
  • Efficiency
    44Asset Turnover 0.77x (1.0+ = capital-efficient)
  • Growth
    57Revenue YoY +12.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project PGR's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 37.9%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$975.51
Total enterprise IV
$573.70B
Diluted shares
0.59B
Terminal PV
$445.43B (78% of total)
Year-5 FCF
$52.49B
YearProjected FCFDiscounted PV
+1$21.50B$19.55B
+2$26.88B$22.21B
+3$33.59B$25.24B
+4$41.99B$28.68B
+5$52.49B$32.59B
Terminal$717.37B$445.43B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$348M
investment in PP&E
Dividends paid (TTM)
$2.87B
cash returned to holders
Stock buybacks (TTM)
share count reduction

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$123.04B
everything owned
Total liabilities
$92.72B
everything owed
Stockholders' equity
$30.32B
shareholder claim
Long-term debt
$2.66B
outstanding bonds + loans

Recent performance · 71 quarters

Revenue↑+12.2% +$2.47B
$22.75B
Net Income↑+25.3% +$595M
$2.95B
Free Cash Flow↑+5.2% +$152M
$3.05B

Drill down